The Use of Intravenous Immunoglobulin (IVIG) during Severe Neurotoxicity Among the Recipients of Chimeric Antigen Receptor T-Cell (CAR-T) Therapy

被引：2
|
作者：
Mokhtari, Sepideh [1 ]
Asquith, Justin M. [2 ]
Bachmeier, Christina A. [3 ]
Jain, Michael D. [3 ]
Forsyth, Peter [1 ]
Locke, Frederick L. [3 ]
Kim, Youngchul [1 ]
Lazaryan, Aleksandr [3 ]
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[2] Univ S Florida, Moffitt Canc Ctr, Tampa, FL 33620 USA
[3] H Lee Moffitt Canc Ctr & Res Inst, Dept Blood & Marrow Transplant & Cellular Immunot, Tampa, FL USA
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-122343
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5627
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Safety profile of chimeric antigen receptor T-cell immunotherapies (CAR-T) in clinical practice
    Bonaldo, Giulia
    Montanaro, Nicola
    Vaccheri, Alberto
    Motola, Domenico
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 77 (08) : 1225 - 1234
  • [32] Chimeric antigen receptor T (CAR-T) cells: Novel cell therapy for hematological malignancies
    Abbasi, Samane
    Totmaj, Milad Asghari
    Abbasi, Masoumeh
    Hajazimian, Saba
    Goleij, Pouya
    Behroozi, Javad
    Shademan, Behrouz
    Isazadeh, Alireza
    Baradaran, Behzad
    CANCER MEDICINE, 2023, 12 (07): : 7844 - 7858
  • [33] Utility and Drawbacks of Chimeric Antigen Receptor T Cell (CAR-T) Therapy in Lung Cancer
    Kandra, Prameela
    Nandigama, Rajender
    Eul, Bastian
    Huber, Magdalena
    Kobold, Sebastian
    Seeger, Werner
    Grimminger, Friedrich
    Savai, Rajkumar
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [34] Chimeric Antigen Receptor (CAR) T-cell Therapy in Neurological Disorders
    Habib, Ali
    Ciurea, Stefan
    Kamboh, Hafsa
    Miljkovic, Milos
    Mozaffar, Tahseen
    NEUROLOGY, 2024, 103 (07) : S119 - S120
  • [35] Chimeric Antigen Receptor (CAR) T-Cell Therapy for Thoracic Malignancies
    Kiesgen, Stefan
    Chicaybam, Leonardo
    Chintala, Navin K.
    Adusumilli, Prasad S.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (01) : 16 - 26
  • [36] Chimeric antigen receptor (CAR) T-cell therapy for multiple myeloma
    Choi, Taewoong
    Kang, Yubin
    PHARMACOLOGY & THERAPEUTICS, 2022, 232
  • [37] DYSGRAPHIA AS THE EARLIEST PRESENTING SYMPTOM OF SEVERE CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPY NEUROTOXICITY: A SINGLE CENTER EXPERIENCE
    Yuen, Carlen
    Rezania, Kourosh
    Kelly, Thomas
    Bishop, Michael
    NEURO-ONCOLOGY, 2021, 23 : 149 - 149
  • [38] Predictors of Failures following Chimeric Antigen Receptor T-cell (CAR T) Therapy
    Figura, N.
    Jain, M.
    Sim, A.
    Dean, E.
    Balagurunathan, Y.
    Chavez, J.
    Shah, B.
    Khimani, F.
    Lazaryan, A.
    Davila, M.
    Liu, H.
    Kim, S.
    Locke, F.
    Robinson, T.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S311 - S312
  • [39] Integrated palliative care for patients referred for Chimeric Antigen Receptor T-cell (CAR-T) therapy: A service evaluation
    Williams, R.
    Droney, J. M.
    Nicholson, E.
    Arias, C.
    Ellard, R.
    Bradley, N.
    Maycock, C.
    Halley, A.
    ANNALS OF ONCOLOGY, 2023, 34 : S892 - S893
  • [40] Risk of gastrointestinal adverse events associated with chimeric antigen receptor T-cell therapy (CAR-T): A nationwide analysis
    Khan, Shahryar
    Asif, Samia
    Khan, Mashal Alam
    Khan, Muhammad Atif
    Amin, Muhammad Kashif
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
12345